Collgium Pharma Files Proxy Statement
Ticker: COLL · Form: DEFA14A · Filed: Mar 28, 2025 · CIK: 1267565
| Field | Detail |
|---|---|
| Company | Collegium Pharmaceutical, Inc (COLL) |
| Form Type | DEFA14A |
| Filed Date | Mar 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, shareholder-meeting, corporate-governance
Related Tickers: COLG
TL;DR
COLG proxy statement filed. Go to envisionreports.com/COL to vote.
AI Summary
Collgium Pharmaceutical, Inc. filed a Definitive Proxy Statement (DEFA14A) on March 28, 2025, detailing matters to be voted on by shareholders. The filing indicates that no fee was required for this filing, and it is related to the company's proxy materials for shareholder meetings. Shareholders are directed to www.envisionreports.com/COL for more information.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda and proposals for the company's annual meeting, allowing them to make informed voting decisions on corporate governance matters.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not contain new financial information or significant corporate actions that would immediately impact stock price.
Key Players & Entities
- COLLEGIUM PHARMACEUTICAL, INC. (company) — Registrant
- 0001104659-25-029374 (filing_id) — Accession Number
- 20250328 (date) — Filing Date
- 100 TECHNOLOGY CENTER DRIVE (address) — Business Address
- STOUGHTON (city) — Business Address City
- MA (state) — Business Address State
- 02072 (zip_code) — Business Address Zip
- 781-713-3699 (phone_number) — Business Phone
- www.envisionreports.com/COL (url) — Shareholder Information Portal
FAQ
What type of filing is this DEFA14A for Collegium Pharmaceutical, Inc.?
This is a Definitive Proxy Statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934.
When was this filing made?
The filing was made on March 28, 2025.
What is the company's primary business classification?
The company is classified under Pharmaceutical Preparations [2834].
Where can shareholders find additional information or vote?
Shareholders are directed to visit www.envisionreports.com/COL.
Was there a filing fee associated with this document?
No fee was required for this filing.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on March 28, 2025 regarding COLLEGIUM PHARMACEUTICAL, INC (COLL).